MALP-2, a Mycoplasma lipopeptide with classical endotoxic properties: end of an era of LPS monopoly?

DOI Web Site 被引用文献2件
  • C. Galanos
    Max-Planck Institut für Immunbiologie, Freiburg, Germany
  • M. Gumenscheimer
    Max-Planck Institut für Immunbiologie, Freiburg, Germany
  • P.F. Mühlradt
    Immunobiology Research Group, GBF, Braunschweig, Germany
  • E. Jirillo
    Department of Immunology, Faculty of Medicina, Policlinico University, Bari, Italy
  • M.A. Freudenberg
    Max-Planck Institut für Immunbiologie, Freiburg, Germany

この論文をさがす

説明

<jats:p> Although some activities of LPS are shared by other bacterial components, for half a century LPS has been regarded as unique in displaying many pathophysiological activities. Here we report on a synthetic lipopeptide, MALP-2 from Mycoplasma fermentans , which expresses potent endotoxin-like activity and whose lethal toxicity is comparable to that of LPS. With the exception of the Limulus lysate gelation test, in which MALP-2 was approximately 1000-fold less active than LPS, the synthetic lipopeptide induced all activities tested for, and in most cases to an extent comparable to that of LPS. Unlike LPS, the biological activities of MALP-2 were expressed both in LPSresponder and in LPS-non-responder mice (BALB/c/l, C57BL10/ScCr), indicating that MALP-2 signaling, unlike that of LPS, is not transduced via the Toll-like receptor (Tlr) 4 protein. MALP-2 expressed no toxicity in normal or sensitized Tlr2 knockout (Tlr2<jats:sup>— /—</jats:sup>) mice indicating that its toxic activity is induced via Tlr2 signaling. The phenomenology of the lethal shock induced by MALP-2 in normal or sensitized mice, i.e. the kinetics of its development and symptoms of illness exhibited by the treated animals, was very reminiscent of the lethal shock induced by LPS. </jats:p>

収録刊行物

被引用文献 (2)*注記

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ